DiaMedica Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 04:28 pm EST
DiaMedica Therapeutics Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 4.47 million compared to USD 3.06 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.12 a year ago.
For the nine months, net loss was USD 14.22 million compared to USD 9.93 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 0.38 a year ago.